ARHI activators are part of a chemical class designed to interact with and modulate the activity of the ARHI protein, also known as aplasia Ras homolog member I or DIRAS3. ARHI is a member of the Ras superfamily of GTPases, which are known for their role in various signal transduction pathways. However, ARHI is unique among its family due to its distinct structure and function. As an atypical GTPase, its regulation is not fully understood, but it is known to be involved in cellular processes that maintain normal cell function. Activators of ARHI can enhance its intrinsic GTPase activity or facilitate its interaction with other regulatory proteins or effectors. These activators typically bind to specific domains on ARHI, inducing conformational changes that either promote its active state or stabilize its interaction with other proteins in the signaling pathway.
The chemical composition of ARHI activators is varied, reflecting the multifaceted approaches used to modulate the protein's activity. They may include small molecules that mimic endogenous ligands or entirely synthetic compounds identified through various screening methods. The development of these activators often involves iterative cycles of structure-activity relationship (SAR) studies, where the effect of chemical modifications on the interaction with ARHI is evaluated. This process aims to optimize the compound's selectivity and potency while ensuring favorable pharmacokinetic properties. In designing ARHI activators, chemists consider the shape and electronic properties of the binding site on ARHI, ensuring that the activators have appropriate functional groups to interact with key amino acid residues.
Items 71 to 12 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|